Swiss in the hunt for growth companies

U.S.-based BioMarin Pharmaceutical is expected to launch the Swiss version of Europe. s high-growth New Market exchanges, as the Zurich-based SWX New Market makes its bid for high growth, high tech companies.

Robert Wyss, product manager for the new market, told Ebb & Flow that he expects SWX to follow the example of Frankfurt. s Neuer Markt and admit only high tech-focused companies, rather than the example of Paris Bourse. s Nouveau Marché, which has allowed less tech-oriented companies to list...